Cardiac Biomarkers market is expected to reach $2,085.9 million by 2020 at a CAGR of 18.9% due to high accuracy, quick outcomes and economic pricing of cardiac point of care.

The Global cardiac biomarkers market is segmented based on type, application, location of testing and geography. Based on cardiac biomarker type, the market is segmented into Creatine Kinase (CK-MB), Troponins T and I, myoglobin, BNPs, IMA and others. Troponins I and T are the highest revenue-generating segment in the overall cardiac biomarker market due to its prodigious specificity and its ability to accurately detect the cardiac events of Acute Coronary Syndrome (ACS).

Get the sample Report: https://www.alliedmarketresearch.com/request-sample/309?utm_source=openpr_Niranjan

Based on application, the market is segmented into myocardial infarction, congestive heart failure, Acute Coronary Syndrome, atherosclerosis and others. Myocardial infarction (MI) holds the highest market share in the global cardiac biomarker market followed by Acute Coronary Syndrome (ACS) due to the highest prevalence rate among cardiovascular diseases (CVDs). The location of a testing segment is classified as the point of care testing and laboratory testing. Doctors and clinicians largely prefer the point of care cardiac testing for quick monitoring patients with chest pain in an emergency care unit, therefore, accounting the fastest CAGR. However, laboratory testing is generating larger revenue in comparison to point of care testing.

Cardiac Biomarkers Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the period 2015-2020. Cardiac Troponins (T, I) would continue to dominate the market throughout the forecast period due to high sensitivity and specificity.

Purchase Report: https://www.alliedmarketresearch.com/checkout/499036?utm_source=openpr_Niranjan

Cardiac biomarkers are protein-based traceable substances used as an indicator of biological state for diagnostic and prognostic purposes associated with cardiac conditions. Commercialization of highly advanced and accurate type of cardiac biomarkers has provided a novel platform for the diagnosis of cardiac diseases. Continuous focus on pipeline research and developments from leading players and increased patient awareness across untapped regions such as India, China is largely driving the growth of cardiac biomarkers market. The growing application of cardiac biomarkers as point of care (POC) testing facilitate quick results in chronic conditions, thus drives the market growth. However, specificity and sensitivity related concerns of single measurement cardiac biomarkers, premium pricing, and certain government regulations would hinder the market growth. Also, the overall market growth would bank on novel progress made in cardiac treatments using multi-assay biomarkers. The life-saving benefits of these multi-assay biomarkers would foster the revenue generation process as well as market penetration of novel cardiac biomarkers in the future.

Key findings of Cardiac Biomarkers Market:
• Troponin segment is projected as a leading market segment throughout the forecast period.
• Revenue of myocardial infarction application segment is expected to grow almost threefold by 2020.
• Laboratory location of testing market segment still dominates the global market.
• Point of care location of a testing segment is projected to grow at a CAGR of 22% during the forecast period.
• Countries like India and China holds prominent potential owing to a higher count of undiagnosed cardiac patients.

About Us:-

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.